Digecitss -ministerio DE Salud Publ Pharmaceutical Import Profile — Dominican Republic (DGFT 2022–2026)

Name: Digecitss -ministerio DE Salud Publ Pharmaceutical Import Records from India — 2 Products, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Digecitss -ministerio DE Salud Publ — Pharmaceutical Importer Profile (2026) | 2 Products, $400.0K Trade | TransData Nexus

Digecitss -ministerio DE Salud Publ

Pharmaceutical Importer · Dominican Republic · Antiviral & HIV Medications Focus · $400.0K Total Trade · DGFT Verified

Digecitss -ministerio DE Salud Publ is a pharmaceutical importer based in Dominican Republic with a total trade value of $400.0K across 2 products in 1 therapeutic categories. Based on 8 verified import shipments from Indian Customs (DGFT) records, Digecitss -ministerio DE Salud Publ is the #1 buyer in 1 product including Atazanavir. Digecitss -ministerio DE Salud Publ sources from 3 verified Indian suppliers, with Mylan Laboratories Limited accounting for 65.7% of imports.

Digecitss -ministerio DE Salud Publ — Import Portfolio & Supplier Network

Digecitss -ministerio DE Salud Publ import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Digecitss -ministerio DE Salud Publ?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$206.2K	5	65.7%
Emcure Pharmaceuticals Limited	$100.0K	2	31.9%
Macleods Pharmaceuticals Limited

What Formulations Does Digecitss -ministerio DE Salud Publ Import?

Formulation	Value	Ships
Anzavir-r(atazanavir 300MG + ritonavir	$200.0K	4
Pharmaceutical products (finished	$100.0K	2
Tenofovir disoproxil fumarate 300MG	$6.2K	1
Zidovudine 50MG/5ML oral solution 240mlbottle (net content 4.0176 kgs zidovudine)	$5.0K	1
Zidovudine 50MG/5ML oral solution 240ML	$1.5K	1
Drugs and pharmaceuticals harmless	$1.1K	1

Digecitss -ministerio DE Salud Publ imports 6 distinct pharmaceutical formulations. Showing top 6 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Atazanavir	Antiviral & HIV Medications	$200.0K	4	0.3%	1
2	Ritonavir	Antiviral & HIV Medications	$200.0K	4	0.1%	7

Digecitss -ministerio DE Salud Publ imports 2 pharmaceutical products across 1 categories into Dominican Republic totaling $400.0K. The company is the #1 buyer for 1 product: Atazanavir.

Digecitss -ministerio DE Salud Publ — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Digecitss, officially known as the Dirección General de Control de las Infecciones de Transmisión Sexual y Sida, is a specialized division within the Dominican Republic's Ministry of Public Health and Social Assistance (MISPAS). Established to oversee the control and prevention of sexually transmitted infections (STIs) and HIV/AIDS, Digecitss plays a pivotal role in the nation's public health infrastructure. Its primary functions include the development and implementation of national strategies for STI and HIV prevention, education, and treatment, as well as the coordination of resources and policies aimed at mitigating the impact of these diseases. While Digecitss is not a pharmaceutical importer or buyer, it collaborates closely with various stakeholders, including pharmaceutical entities, to ensure the availability and distribution of essential medications for the treatment and prevention of HIV/AIDS and other STIs.

2Distribution Network

As a governmental health agency, Digecitss does not operate a traditional distribution network for pharmaceutical products. Instead, it partners with authorized pharmaceutical importers and distributors within the Dominican Republic to facilitate the procurement and distribution of medications necessary for the national response to HIV/AIDS and other STIs. These collaborations ensure that essential medicines are accessible to healthcare facilities and patients across the country.

3Industry Role

Digecitss serves as a central coordinating body within the Dominican Republic's pharmaceutical supply chain, particularly concerning the procurement and distribution of medications for the treatment and prevention of HIV/AIDS and other STIs. While it does not function as a pharmaceutical importer or distributor itself, Digecitss plays a critical role in ensuring that the necessary medications are available and accessible to the population. This involves working with various stakeholders, including pharmaceutical companies, importers, and healthcare providers, to facilitate the effective delivery of healthcare services related to STI and HIV prevention and treatment.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Digecitss -ministerio DE Salud Publ

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Digecitss's procurement strategy for HIV/AIDS and STI medications involves sourcing from a diverse range of pharmaceutical suppliers to ensure a stable and uninterrupted supply of essential medicines. By collaborating with multiple suppliers, Digecitss mitigates the risks associated with single-source dependency, such as supply chain disruptions or price fluctuations. This approach enhances the resilience and reliability of the pharmaceutical supply chain, ensuring that patients have continuous access to necessary treatments.

2Supply Chain Resilience

The resilience of Digecitss's pharmaceutical supply chain is bolstered by its strategic partnerships with multiple suppliers, including those from India. This diversification ensures that the supply chain is not overly reliant on a single source, reducing the risk of disruptions due to geopolitical issues, regulatory changes, or other unforeseen events. Additionally, by sourcing from suppliers with recognized Good Manufacturing Practices (GMP) certifications, Digecitss ensures that the medications meet international quality standards, further strengthening the integrity and reliability of the supply chain.

3Strategic Implications

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Dominican Republic

1Regulatory Authority & Framework

The primary regulatory authority overseeing pharmaceutical imports in the Dominican Republic is the Ministry of Public Health and Social Assistance (MISPAS), specifically through the General Directorate of Medicines, Food, and Health Products (DIGEMAPS). This body is responsible for ensuring that all pharmaceutical products entering the country meet the required safety, efficacy, and quality standards. The regulatory framework governing pharmaceutical imports includes the General Health Law and Regulation No. 246-06 on Medicines, which outline the procedures and requirements for the registration, importation, and distribution of pharmaceutical products. These regulations are designed to protect public health by ensuring that only safe and effective medications are available in the Dominican market.

2Import Licensing & GMP

Importers of pharmaceutical products into the Dominican Republic must obtain a Sanitary Register from DIGEMAPS for each product they intend to import. This registration process involves submitting a comprehensive technical dossier that includes evidence of compliance with Good Manufacturing Practices (GMP), product specifications, labeling information, and other relevant documentation. The Sanitary Register is valid for five years and must be renewed upon expiration. Additionally, importers must adhere to customs regulations, including registration with the General Directorate of Customs (DGA) and compliance with import procedures. Working with licensed customs brokers is recommended to navigate the complexities of the import process effectively.

Digecitss -ministerio DE Salud Publ — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Digecitss's focus on HIV/AIDS and STI medications aligns with the significant public health challenges posed by these diseases in the Dominican Republic. The high prevalence of HIV/AIDS necessitates a robust response, including the availability of effective treatments and preventive measures. By prioritizing these therapeutic areas, Digecitss aims to reduce transmission rates, improve patient outcomes, and enhance the overall quality of life for individuals affected by these conditions. The strategic emphasis on HIV/AIDS and STI medications is driven by both domestic health needs and international commitments to combat these diseases.

2Sourcing Profile

Digecitss's sourcing strategy for HIV/AIDS and STI medications involves procuring products from a diverse range of suppliers, including those from India. This approach ensures a stable and uninterrupted supply of essential medicines, mitigating risks associated with single-source dependency. The focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), allows for more efficient distribution and ensures that medications are ready for patient use upon arrival. By sourcing from suppliers with recognized GMP certifications, Digecitss ensures that the imported products meet international quality standards, thereby safeguarding public health.

Market Positioning

Seller's Guide — How to Become a Supplier to Digecitss -ministerio DE Salud Publ

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For Indian pharmaceutical exporters, the Dominican Republic presents a promising market for HIV/AIDS and STI medications. Digecitss's diversified sourcing strategy indicates an openness to engaging with new suppliers who can meet the required quality standards and regulatory requirements. Establishing partnerships with Digecitss and other stakeholders can lead to increased market penetration and contribute to the global effort in combating these diseases. However, potential suppliers must be prepared to navigate the regulatory complexities of the Dominican market and demonstrate compliance with GMP standards recognized by Dominican authorities.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to the Dominican Republic must ensure that their products are registered with DIGEMAPS and comply with the Sanitary Register requirements. This includes providing a comprehensive technical dossier, evidence of GMP compliance, and labeling information in Spanish. Additionally, exporters must adhere to customs regulations, including registration with the DGA and compliance with import procedures. Working with licensed customs brokers and regulatory experts is recommended to navigate the complexities of the import process effectively.

Frequently Asked Questions — Digecitss -ministerio DE Salud Publ

What products does Digecitss -ministerio DE Salud Publ import from India?

Digecitss -ministerio DE Salud Publ imports 2 pharmaceutical products across 1 categories. Top imports: Atazanavir ($200.0K), Ritonavir ($200.0K).

Who supplies pharmaceuticals to Digecitss -ministerio DE Salud Publ from India?

Digecitss -ministerio DE Salud Publ sources from 3 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (65.7% of imports, $206.2K).

What is Digecitss -ministerio DE Salud Publ's total pharmaceutical import value?

Digecitss -ministerio DE Salud Publ's total pharmaceutical import value from India is $400.0K, based on 8 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Digecitss -ministerio DE Salud Publ focus on?

Digecitss -ministerio DE Salud Publ imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Digecitss -ministerio DE Salud Publ Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.